Radcliffe Capital Management’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$905 704
2023
Q1
$905 Hold
100,000
﹤0.01% 685
2022
Q4
$29K Hold
100,000
﹤0.01% 876
2022
Q3
$108K Hold
100,000
﹤0.01% 1173
2022
Q2
$154K Hold
100,000
﹤0.01% 1203
2022
Q1
$559K Buy
+100,000
New +$23.4K 0.01% 1103

Radcliffe Capital Management's GLS.WS Position: Q2 2023 in Review

Radcliffe Capital Management sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q2 2023, closing a stake of 100,000 shares — an estimated $905 sold.

Radcliffe Capital Management first reported a position in GLS.WS in Q1 2022 and held it in 5 quarters. The position peaked at $559K in Q1 2022. 0 funds tracked by Wall St. Rank hold GLS.WS as of Q2 2023.

  • Radcliffe Capital Management reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 100,000 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q2 2023, an estimated $905.
  • Radcliffe Capital Management first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 5 quarters.
  • Radcliffe Capital Management's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $559K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q2 2023.

Based on Radcliffe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.